Citigroup’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-122
| Closed | -$221 | – | 5053 |
|
|
2023
Q2 | $221 | Buy |
122
+69
| +130% | +$125 | ﹤0.01% | 4664 |
|
|
2023
Q1 | $70 | Sell |
53
-178
| -77% | -$235 | ﹤0.01% | 4571 |
|
|
2022
Q4 | $390 | Sell |
231
-290
| -56% | -$490 | ﹤0.01% | 4738 |
|
|
2022
Q3 | $1K | Sell |
521
-1,261
| -71% | -$2.42K | ﹤0.01% | 4900 |
|
|
2022
Q2 | $5K | Sell |
1,782
-1,049
| -37% | -$2.94K | ﹤0.01% | 4872 |
|
|
2022
Q1 | $20K | Buy |
+2,831
| New | +$20K | ﹤0.01% | 4417 |
|